Viewing Study NCT02446457


Ignite Creation Date: 2025-12-24 @ 6:58 PM
Ignite Modification Date: 2026-01-05 @ 5:47 PM
Study NCT ID: NCT02446457
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2025-10-03
First Post: 2015-05-13
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Rituximab and Pembrolizumab With or Without Lenalidomide in Treating Patients With Relapsed Follicular Lymphoma and Diffuse Large B-Cell Lymphoma
Sponsor: M.D. Anderson Cancer Center
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module